Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00600665 · ClinicalTrials.gov registry record · NA

Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease

A NA study of Anemia, Sickle Cell and Hemoglobin SC Disease, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
279
Enrollment target
1
Study location

NCT00600665 is a NA study of Anemia, Sickle Cell and Hemoglobin SC Disease that has completed, run by University of Illinois at Chicago. The registered enrollment target is 279 participants, above the 102-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (174% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00600665, a NA study of Anemia, Sickle Cell and Hemoglobin SC Disease, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
279 participants
Enrollment target
1
Study location

Study Summary

Sickle cell disease (SCD) is a blood disorder that is characterized by intense, painful episodes known as sickle cell crises. This study will evaluate the effectiveness of PAINRelieveIt, a three-part computer-based pain management tool, in treating adults with SCD.

Interventions

  • BEHAVIORAL PAINReportIt
  • BEHAVIORAL PAINUCope
  • BEHAVIORAL PAINConsultN

Study Locations (1)

Illinois

  • University of Illinois at Chicago Sickle Cell Center and Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 279 participants
Start Date 2007-02
Est. Completion 2014-06
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT00600665

The ClinicalTrials.gov registry entry for NCT00600665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 102-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (174% higher). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 3 interventions - of which PAINReportIt is the first listed.

NCT00600665 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00600665 about?

NCT00600665 is a clinical study titled "Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease". Sickle cell disease (SCD) is a blood disorder that is characterized by intense, painful episodes known as sickle cell crises. This study will evaluate the effectiveness of PAINRelieveIt, a three-part computer-based pain management tool, in treating adults with SCD.

What is the current status of trial NCT00600665?

This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2007-02. Estimated completion is 2014-06.

What conditions does trial NCT00600665 study?

This clinical trial studies the following conditions: Anemia, Sickle Cell, Hemoglobin SC Disease.

What interventions are being tested in trial NCT00600665?

The interventions under investigation include: PAINReportIt (BEHAVIORAL), PAINUCope (BEHAVIORAL), PAINConsultN (BEHAVIORAL).

Who is sponsoring clinical trial NCT00600665?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00600665 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia, Sickle Cell

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.